Glucocorticoid-Induced Osteoporosis

Alanna M.K. Dubrovsky, Michael Maricic, Nancy E. Lane

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Harvey Cushing first described the association between excess endogenous glucocorticoids and fractures in 1932. By 1954, a few years after the introduction of prednisone to treat rheumatoid arthritis, the deleterious skeletal effects of exogenous glucocorticoids were reported. Glucocorticoid-induced bone loss is now the most common form of secondary osteoporosis and fractures are glucocorticoids’ most common adverse effect. They are among the most common iatrogenic complications of clinical practice as glucocorticoids are used by 0.5–2.5% of adults. Concomitant factors including the underlying disease for which patients are treated, age, baseline bone mineral density (BMD), the hormonal status of the patient, and individual differences in sensitivity to glucocorticoid also play a role in determining whether or not a patient will develop osteoporosis and fractures. Trabecular bone score and the fracture risk assessment tool have increased physicians’ ability to effectively diagnose glucocorticoid-induced osteoporosis, and randomized clinical controlled trials now guide treatment decisions, allowing for clear recommendations outlined in this chapter.

Original languageEnglish (US)
Title of host publicationContemporary Endocrinology
PublisherHumana Press Inc.
Pages407-418
Number of pages12
DOIs
StatePublished - Jan 1 2020

Publication series

NameContemporary Endocrinology
ISSN (Print)2523-3785
ISSN (Electronic)2523-3793

Keywords

  • Bone mineral density
  • Bone remodeling
  • Exogenous glucocorticoids
  • Fracture risk assessment tool
  • Glucocorticoid-induced bone loss
  • Glucocorticoid-induced osteoporosis
  • Parathyroid hormone
  • Trabecular bone score

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'Glucocorticoid-Induced Osteoporosis'. Together they form a unique fingerprint.

  • Cite this

    Dubrovsky, A. M. K., Maricic, M., & Lane, N. E. (2020). Glucocorticoid-Induced Osteoporosis. In Contemporary Endocrinology (pp. 407-418). (Contemporary Endocrinology). Humana Press Inc.. https://doi.org/10.1007/978-3-319-69287-6_21